Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385).
Leaf, A N
Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385). [electronic resource] - Medical oncology (Northwood, London, England) Feb 2000 - 47-51 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
1357-0560
10.1007/BF02826216 doi
Adult
Aged
Antineoplastic Agents, Phytogenic--therapeutic use
Disease Progression
Etoposide--therapeutic use
Female
Humans
Iodine Radioisotopes--therapeutic use
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Sample Size
Thyroid Hormones--therapeutic use
Thyroid Neoplasms--drug therapy
Treatment Outcome
Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385). [electronic resource] - Medical oncology (Northwood, London, England) Feb 2000 - 47-51 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
1357-0560
10.1007/BF02826216 doi
Adult
Aged
Antineoplastic Agents, Phytogenic--therapeutic use
Disease Progression
Etoposide--therapeutic use
Female
Humans
Iodine Radioisotopes--therapeutic use
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Sample Size
Thyroid Hormones--therapeutic use
Thyroid Neoplasms--drug therapy
Treatment Outcome